Clinical relevance of sentinel lymph node status examined with conventional histology and molecular biology

Tumori

Volumn 95, Issue 3, 2009, Pages 298-302

  Micciolo, Rocco ^a,d   Boi, Sebastiana ^b   Paoli, Loredana ^b   Cristofolini, Paolo ^b   Girlando, Salvatore ^b   Dalla Palma, Paolo ^b   Cristofolini, Mario ^c  

^a UNIVERSITY OF TRENTO   (Italy)

^b SANTA CHIARA HOSPITAL   (Italy)

^c Italian League Against Cancer   (Italy)

^d NONE   (Italy)

Author keywords

Disease free period; Melanoma; Overall survival; Sentinel lymph node biopsy

Indexed keywords

ARTICLE; CANCER INVASION; DISEASE FREE INTERVAL; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MELANOMA; MOLECULAR BIOLOGY; OVERALL SURVIVAL; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; SKIN CANCER;

BIOLOGICAL BEHAVIOR; DISEASE-FREE PERIOD; IMMUNOHISTOCHEMISTRY; MELANOMA; OVERALL SURVIVAL; PROGNOSTIC FACTORS; SENTINEL LYMPH NODE BIOPSIES; SENTINEL LYMPH NODES;

BIOMOLECULES; BIOPHYSICS; BIOPSY; DERMATOLOGY; HISTOLOGY; ONCOLOGY;

BODY FLUIDS;

EID: 67849116599     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160909500305     Document Type: Article

References (24)

1. Balch C, Cascinelli N: Sentinel lymph node biopsy in melanoma. N Engl J Med, 355: 1370-1371, 2006.
2. Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, Essner R: Sentinel lymph node-biopsy or nodal observation in melanoma. N Engl J Med, 355: 1307-1317, 2006.
3. Cascinelli N, Bombardieri E, Bufalino R, Camerini T, Carbone A, Clemente C, Lenisa L, Mascheroni L, Maurichi A, Pennacchioli E, Patuzzo R, Santinami M, Tragni G: Sentinel and non-sentinel node status in stage IB and II melanoma patients: two step prognostic indicators of survival. J Clin Oncol, 24: 4464-4471, 2006.
4. Spancnebel K, Coit DG, Bieligk SC, Gonen M, Rosai J, Klimstra DS: Characterization of micrometastatic disease in melanoma sentinel nodes by enhanced pathology. Recommendations for standardizing pathologic analysis. Am J Surg Pathol, 29: 306-317, 2005. (Pubitemid 40321965)
5. Berk DR, Johnson DL, Uzieblo A, Kiernan M, Swetter SM: Sentinel lymph node biopsy for cutaneous melanoma. The Stanford experience, 1997-2004. Arch Dermatol, 141: 1016-1022, 2005.
6. Maccauro M, Villano C, Aliberti G, Ferrari L, Castellani R, Patuzzo R, Tshering D, Santinami M, Bombardieri E: Lymphoscintigraphy with intraoperative gamma probe sentinel node detection: clinical impact in patients with head and neck melanomas. Q J Nucl Med Mol Imaging, 49: 245-251, 2005. (Pubitemid 41569512)
7. Van Akkooi ACJ, De Wilt JHW, Verhoef C, Schmitz PIM, Van Geel AN, Eggermont AMM, Kliffen M: Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative? Ann Oncol, 17: 1578-1585, 2006.
8. Sabel MF, Griffith K, Sondack VK, Lowe L, Schwartz JL, Cimmino VM, Chang AE, Rees RS, Bradford CR, Johnson TM: Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma. J Am Coll Surg, 201: 37-47, 2005. (Pubitemid 40840562)
9. Bonin S, Niccolini B, Calacione R, Gambardella B, Geatti O, Stanta G, Trevisan G: Molecular analyses of sentinel lymph nodes: an open question. J Eur Acad Dermatol Venereol, 16: 34-39, 2002. (Pubitemid 34202000)
10. Boi S, Cristofolini P, Togni R, Girlando S, Donner D, Cristofolini M, Dalla Palma P: Detection of nodal micrometastasis using immunohistochemistry and PCR in melanoma of the arm and trunk. Melanoma Res, 12: 147-153, 2002.
11. Shivers SC, Li W, Lin J, Stall A, Stafford M, Messina J, Glass LF, Reintgen DS: The clinical relevance of molecular staging for melanoma. Recent Result Cancer Res, 158: 187-199, 2001.
12. Mangas C, Hilari JM, Paradelo C, Rex J, Fernandez-Figueras MT, Fraile M, Alastrue A, Ferrandiz C: Prognostic significance of molecular staging study of sentinel lymph nodes by reverse transcriptase-polymerase chain reaction for tyrosinase in melanoma patients. Ann Surg Oncol, 13: 910-918, 2006. (Pubitemid 43920922)
13. Romanini A, Manca G, Pellegrino D, Murr R, Sarti S, Bianchi F, Alsharif A, Orlandini C, Zucchi V, Castagna M, Gandini D, Salimbeni G, Ghiara F, Barachini P, Mariani G: Molecular staging of the sentinel lymph node in melanoma patients: correlation with clinical outcome. Ann Oncol, 16: 1832-1840, 2005.
14. Kaplan EL, Meier P: Nonparametric estimation from incomplete observation. J Am Stat Assoc, 53: 457-481, 1958.
15. Cox DR: Regression models and life tables (with discussion). J R Statist Soc B, 34: 187-220, 1972.
16. Lee JH, Essner R, Torisu-Itakura H, Wanek L, Wang H, Morton DI: Factors predictive of tumor-positive sentinel lymph node dissection for melanoma. J Clin Oncol, 22: 3677-3684, 2004.
17. Fincher TR, McCarty TM, Fisher TL, Preskitt JT, Lieberman ZH, Stephens JF, O'Brien J, Kuhn JA: Patterns of recurrence after sentinel lymph node biopsy for cutaneous melanoma. Am J Surg, 186: 675-681, 2003. (Pubitemid 37522105)
18. Leong SPL, Accort NA, Essner R, Ross M, Gershenwald JE, Pockaj B, Hoeckstra HJ, Garberoglio C, White RL, Chu D, Biel M, Charney K, Wanebo H, Avisar E, Vetto J, Soong S: Impact of sentinel node status and other risk factors on the clinical outcome of head and neck melanoma patients. Arch Otolaringol Head Neck Surg, 132: 370-373, 2006.
19. Cherpelis BS, Haddad F, Messina J, Cantor AB, Fitzmorris K, Reintgen DS, Fenske NA, Glass F: Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas. J Am Acad Dermatol, 44: 762-766, 2001. (Pubitemid 32391162)
20. Shivers SC, Wang X, Li W, Joseph E, Messina J, Glass LF, Deconti R, Cruse CW, Berman C, Fenske NA, Lyman GH, Reintgen DS.: Molecular staging of malignant melanoma: Correlation with clinical outcome. JAMA, 280: 1410-1415, 1998.
21. Kuo CT, Hoon DS, Takeuchi H, Turner R, Wang HJ, Morton DL, Taback B: Prediction of disease outcome in melanoma patients by molecular analysis of paraffin-embedded sentinel lymph nodes. J Clin Oncol, 21: 3566-3572, 2003. (Pubitemid 46594047)
22. McMasters KM, Noyes RD, Reintgen DS, Goydos JS, Beitsch PD, Davidson BS, Sussman JJ, Gershenwald JE, Ross MI For The Sunbelt Melanoma Trial: Lessons learned from the Sunbelt Melanoma Trial. J Surg Oncol, 86: 212-223, 2004. (Pubitemid 38880288)
23. Mocellin S, Hoon DSB, Pilati P, Rossi CR, Nitti D: Sentinel lymph node molecular ultrastaging in patients with melanoma: a systematic review and meta-analysis of prognosis. J Clin Oncol, 25: 1588-1595, 2007. (Pubitemid 46733087)
24. Hilari JM, Mangas C, Xi L, Paradelo C, Ferràndiz C, Hughes SJ, Yueh C, Altomare I, Gooding WE, Godfrey TE: Molecular staging of pathologically negative sentinel lymph nodes from melanoma patients using multimarker, quantitative real-time RT-PCR. Ann Surg Oncol, 2008 Nov 4 (Epub ahead of print)